Om Research


In collaboration with the University of Michigan, we published our first IRB-approved study in 2016 and are currently in the process of our second research study! 

Our First Research Study:

We conducted a survey of 244 medical cannabis patients in Michigan with chronic pain for 3 months. Our goal was to collect data to examine if  using medical cannabis for chronic pain affected one’s opioid consumption as well. We saw testimonial evidence of this everyday in our consultation rooms. Click the link below to read our study that was published in the Journal of Pain!

Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain (2016)


Three Major Conclusions: 
      1. Cannabis use was associated with 64% lower opioid use in patients with chronic pain.
      2. Cannabis use was associated with better quality of life in patients with chronic pain.
      3. Cannabis use was associated with fewer medication side effects and medications used.
Impact Since Published:  

After publication in 2016, our study has been cited in several important reports including

Our Ongoing Second Study:

We partnered again with the University of Michigan and received IRB-approval for our second research study in 2018, titled: “Longitudinal examination of medical cannabis for central nervous system pain reduction.”

Our goal is to further examine how cannabis use is related to pain management, quality of life, and the use of other medications. We can use the information collected to not only help our patients directly but help inform physicians, researchers, policy-makers about the potential benefits and risk of cannabis as a therapeutic agent.


  • There are the 3 qualifications needed for eligibility: 
    1. You are 18 years of age or older.
    2. You have either been using cannabis for chronic pain management for less than three months OR you plan to but have not started using cannabis for chronic pain management.
    3. You have a medical cannabis certification in your state of residence.
  • If you are interested in participating, please contact:
    • Kevin Boehnke at
  • Flyer of Second Study

Sign up to receive emails about promotions, events, policy reform, and more!

You have successfully subscribed to Om's mailing list!

There was an error while trying to send your request. Please try again.

Om of Medicine will use the information you provide on this form to be in touch with you and to provide updates and marketing.